Dr. Lori McDonald has been named vice president, quality and compliance at MDS Pharma Services. Dr. McDonald will lead the company’s ongoing program to build and manage quality and regulatory compliance systems across its global business platforms.
   
“I’m delighted that Dr. McDonald has joined our leadership team,” said president David Spaight. “By enabling process improvements and compliance with regulatory requirements, she and her staff will be instrumental in helping MDS Pharma Services deliver high-quality, on-time services. This will help our clients expedite their drug discovery and development programs.”
   
Dr. McDonald previously served as vice president, regulatory affairs with Alder Biopharmaceuticals. From 2001 to 2006, Dr. McDonald held a series of leadership roles with Cardinal Health, most recently having served as executive director, regulatory affairs. Prior to that, she worked at Ligand Pharmaceuticals and Abbott Laboratories.